LaunchOne Acquisition Corp

Contributing Author

Recent Articles by LaunchOne Acquisition Corp

Jan-13	Minovia Therapeutics Announces Two New U.S. Patents Granted, Strengthening Its Mitochondrial Augmentation Therapy Platform LPAA GlobeNewswire
Nov-20	Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition LPAA GlobeNewswire
Oct-15	Minovia Therapeutics Receives FDA Orphan Drug Designation for MNV-201 in Myelodysplastic Syndrome LPAA GlobeNewswire
Sep-18	Minovia Therapeutics Receives FDA Fast Track Designation for MNV-201 in Myelodysplastic Syndrome LPAA GlobeNewswire
Aug-27	Minovia Therapeutics Announces $350,000 Grant from Countdown for a Cure Foundation to Develop Mitochondria Blood-Based Biomarkers LPAA GlobeNewswire
Jul-24	Minovia Therapeutics Announces Interim Data from Phase 2 Trial in Pearson Syndrome Demonstrating No Treatment-Related Serious Adverse Events and Preliminary Signal for Efficacy Measured by Growth LPAA GlobeNewswire
Jun-30	Minovia Therapeutics Announces FDA Fast Track and Rare Pediatric Disease Designations for MNV-201 in Pearson Syndrome LPAA GlobeNewswire